Back to Search Start Over

Acetazolamide: an improved treatment for lithium‐induced NDI? (LB726)

Authors :
Anne P. Sinke
Jack F.M. Wetzels
Peter M.T. Deen
Theun de Groot
Ruben Baumgarten
Marleen L. A. Kortenoeven
Jan Loffing
Olivier Devuyst
Source :
The FASEB Journal. 28
Publication Year :
2014
Publisher :
Wiley, 2014.

Abstract

Lithium causes nephrogenic diabetes insipidus (Li-NDI) and hydrochlorothiazide (HCTZ) forms, together with amiloride, the mainstay treatment for Li-NDI patients. Earlier, we found that HCTZ, primar...

Subjects

Subjects :
medicine.medical_specialty
Lithium (medication)
business.industry
Urology
Nephrogenic diabetes insipidus
medicine.disease
Biochemistry
Amiloride
Hydrochlorothiazide
Genetics
medicine
Acetazolamide
business
Molecular Biology
Biotechnology
medicine.drug

Details

ISSN :
15306860 and 08926638
Volume :
28
Database :
OpenAIRE
Journal :
The FASEB Journal
Accession number :
edsair.doi...........90f26e2fd8d7904643a7abfb37d2edbe
Full Text :
https://doi.org/10.1096/fasebj.28.1_supplement.lb726
Full Text Access
View/download PDF

Tools

Authors Abstract Subjects Details